Medical White Papers

RSS

Medical White Papers are in-depth articles aimed to educate and inform site visitors interested in medical research. Some of these papers are derived from sources where we have existing commercial relationships. Such articles are clearly labelled as sponsored content and are only accepted when the content is deemed to add value to the core editorial ethos of News Medical.

Reducing the impact of tuberculosis worldwide

Reducing the impact of tuberculosis worldwide

Tuberculosis (TB) is still one the top 10 causes of death in the world, while it's both preventable and curable.

From Cerba Research 16 Mar 2023

How to get clearer test results on monoclonal antibodies

How to get clearer test results on monoclonal antibodies

Monoclonal antibodies could be used as myeloma treatments and can be identified by serum protein electrophoresis and immunofixation electrophoresis.

From Cerba Research 16 Mar 2023

Clinical trial efficiency aided by AI-driven insights

Clinical trial efficiency aided by AI-driven insights

Cerba Research are deploying state-of-the-art AI to generate early insights in order to optimize processes and procedures.

From Cerba Research 16 Mar 2023

Project management is key to successful clinical development

Project management is key to successful clinical development

A roster of top scientists and optimized procedures make Cerba a partner of choice for your project management and to successfully conduct any kind of clinical trials.

From Cerba Research 16 Mar 2023

New area of cancer research

New area of cancer research

This article explains Cerba Research’s patient and science-driven approach towards cancer research.

From Cerba Research 16 Mar 2023

State-of-the-art Storage Facilities for Clinical Trial Samples

State-of-the-art Storage Facilities for Clinical Trial Samples

This article describes storage site and leading cutting edge biobank features found at Cerba Research.

From Cerba Research 16 Mar 2023

Cerba Research offers a customized, innovative approach to their partners

Cerba Research offers a customized, innovative approach to their partners

Cerba Research has built a reputation as a trusted partner committed to ensuring the entirety of our network benefits fully from our customized services and scientific solutions.

From Cerba Research 16 Mar 2023

Developing effective treatments and vaccines to control infectious diseases

Developing effective treatments and vaccines to control infectious diseases

Infectious diseases are on the rise, and currently account for 25% of worldwide deaths.

From Cerba Research 16 Mar 2023

How the Shape of Clinical Trials is Changing

How the Shape of Clinical Trials is Changing

This article outlines how the role of Cerba Research is changing as clinical trials and studies and lab tests evolve through advancing technology.

From Cerba Research 16 Mar 2023

Investigating human glioblastoma tissues using a multiplex panel

Investigating human glioblastoma tissues using a multiplex panel

This article explores the microglia and macrophage populations in human glioblastoma tissue and how their phenotyping and spatial analysis could be potentially applied to clinical studies.

From Cerba Research 16 Mar 2023

Unlocking the potential of mass spectrometry-based protein analysis

Unlocking the potential of mass spectrometry-based protein analysis

As bioanalytics and life sciences are one of the main tracks at this year’s Pittcon, attendees will have the opportunity to learn about the latest innovation in MS-based methods of protein analysis.

From Pittcon 15 Mar 2023

What are the pitfalls of flow chemistry according to academics and industry professionals?

What are the pitfalls of flow chemistry according to academics and industry professionals?

Researchers have shared their 'pain points' of working in flow chemistry.

From H.E.L Group 13 Mar 2023

The effects of microplastics on health

The effects of microplastics on health

Microplastics seem to be omnipresent. But what do we know of their effects on health, and how can we measure them?

From LECO Corporation 10 Mar 2023

The importance of using the right tool – Deliberate deconvolution

The importance of using the right tool – Deliberate deconvolution

In this article, LECO recounts a success story around deliberate deconvolution, when a laboratory requires the assistance of state-of-the-art equipment.

From LECO Corporation 10 Mar 2023

Natural vs. Synthetic: analyzing cannabinoids for pharmaceutical and regulatory purposes

Natural vs. Synthetic: analyzing cannabinoids for pharmaceutical and regulatory purposes

As one of the main tracks at this year’s Pittcon, researchers will outline several studies that have analyzed and characterized cannabis and psychoactive substances.

From Pittcon 2 Mar 2023

Transcript and protein level immune-checkpoint analysis of glioma

Transcript and protein level immune-checkpoint analysis of glioma

This article describes how immune-checkpoint analysis of glioma can be conducted at transcription and protein level.

From TissueGnostics 1 Mar 2023

Optimizing antibody development through recombinant antibody services

Optimizing antibody development through recombinant antibody services

In this article, ACROBiosystems discusses how their recombinant antibody services can be utilized in order to optimize general antibody development.

From ACROBiosystems 1 Mar 2023

How the Controlled Substances Act impacts chemical suppliers & manufacturers

How the Controlled Substances Act impacts chemical suppliers & manufacturers

This article looks at how the controlled substances act impacts chemical suppliers and manufacturers.

From Scitegrity 23 Feb 2023

Process analytical technology (PAT) for biopharmaceuticals and nanomedicines

Process analytical technology (PAT) for biopharmaceuticals and nanomedicines

This white paper reviews the context of multi-angle light scattering as an analytical technology for biopharmaceuticals and nanomedicines.

From Waters | Wyatt Technology 22 Feb 2023

Development and validation of a protocol for characterizing lipid nanoparticles for RNA delivery

Development and validation of a protocol for characterizing lipid nanoparticles for RNA delivery

This app note looks at how to meet regulatory needs in the characterization of lipid nanoparticles for RNA delivery.

From Waters | Wyatt Technology 22 Feb 2023

Previous
1
...
27
28
29
30
31
32
33
...
49
Next

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.